Content about New York

NEW YORK — Coty Inc., an emerging global leader in beauty, announced today that it has added Olivier Goudet , partner and chief executive officer of the Joh. A. Benckiser Group, to the company's board of directors.

Goudet replaces Bernd Beetz, who stepped down from Coty's Board to pursue other interests. JAB is a privately held group that owns and invests in premium brands; it is also Coty's majority shareholder.

NEW YORK — A Harris Interactive poll released Tuesday found that 44% of all adults reported getting their flu shot this past season, the second time flu shot penetration has reached that high in four years, and even more are expected to get a flu shot next season. Almost half of consumers had reported getting the flu shot in the previous season in April 2011.

NEW YORK — The National Advertising Division last week recommended that USPLabs discontinue all claims reviewed by NAD for the company’s Jack3d and Jack3d Micro dietary supplements. USPLabs has agreed to discontinue the claims, NAD reported.

USPLabs further agreed to add language to make clear that Jack3d is a pre-workout product meant to be used in conjunction with exercise.

NEW YORK — Vichy Laboratories, in conjunction with the kickoff for National Women's Health Week, today announced the launch of new additions of skin care products for 50-something women designed to address the signs of hormonal aging.

NEW YORK — Senior U.S. District Judge Edward Korman on Friday denied a Food and Drug Administration motion for a stay pending an appeal of Korman's earlier decision that all levonorgestrel-based emergency contraceptives be available without a prescription and without any age restrictions. 

However, Korman did grant a stay "pending the hearing or submission of the defendants’ motion for a stay in the Court of Appeals on the condition that the motion for a stay be filed by noon on May 13, 2013."

NEW YORK — Target is beta testing a new app that allows users to save on items and share deals on Facebook.

A Bullseye View, Target's online magazine, announced the introduction of Cartwheel, where people can find offers on products by browsing the system or looking at friends' activites, and add up to 10 of their favorites to a list. Once a red check appears in the corner of the offer card, the item can be purchased, and customers can either print a special barcode from their desktop computers or use their mobile devices in-store to access it.

NEW YORK — Ethnic beauty industry veteran Brian K. Marks and his wife, former model Nene Marks, have introduced the new Nene's Secret hair care collection. 

NEW YORK — BrightLine, a provider of interactive television solutions for entertainment and advertising, and cosmetics brand Maybelline New York have announced the launch of a flagship collaborative experience amplifying NBC’s “Fashion Star,” showcasing Maybelline New York products and makeup artist tutorials straight from the “Fashion Star” runway.

NEW YORK — Move Collective, LLC, the creators of bobble, have engineered a durable reusable water bottle for driven athletes everywhere: bobble sport.

CARSON, Calif. — Sato Pharmaceutical, maker of ZenTrip, an over-the-counter motion sickness remedy, recently completed an outdoor urban panel promotion with Duane Reade drug stores in New York, driving trial to the remedy’s thin-film medicated strip.

Street-level displays were strategically placed throughout New York at subway entrances to reach multiple audiences with increased frequency, noted Russ Allison, Sato general manager U.S. 

NEW YORK — The seventh annual Delete Blood Cancer Gala held on May 1 at Cipriani Wall Street broke all records of previous years and raised $3.7 million to support the fight against leukemia and other blood-related cancers. The money raised jointly by beauty company Coty Inc. and Delete Blood Cancer, part of the world's largest bone marrow donor center, will help register 55,000 new bone marrow donors and help patients worldwide.

NEW YORK — Florida's state legislature approved a bill last week that will allow pharmacists to substitute biosimilars for brand name biotech drugs.

The bill, which was approved last Tuesday and is scheduled to take effect on July 1, institutes requirements for pharmacists to substitute biosimilars when they are determined to be biosimilar to and interchangeable with the brand name product, while also requiring the state board of pharmacy to maintain a current list of interchangeable products.